Save time and get answers to complex questions with AI chat
Are there specific stretches to avoid while on lipitor?When will tenofovir alafenide come off patent in canada?How long have hydroxyzine pamoate been on the market?Xiaflex market launch year?Are there income restrictions for lipitor's patient program?
See the DrugPatentWatch profile for Imbruvica
Imbruvica’s generic (active ingredient) name is ibrutinib.[1]
Imbruvica (ibrutinib) is prescribed for certain blood cancers and related conditions, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).[1]
If an “Imbruvica generic” is listed, it refers to a product containing ibrutinib (the same active ingredient). Availability can depend on local approvals and patent/exclusivity status.[1]
[1] https://www.drugpatentwatch.com/patent/ibrutinib
Other Questions About Imbruvica :